
JB Chemicals and Pharmaceuticals Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Torrent Merger
JB Chemicals merged into Torrent Pharma on 8 July 2026 at 51:100. Implied value Rs 2,425 per JB share (5 Oct 2026 close of Torrent).
Updated: 6 Oct 2026 • 12:54 pm
Posted by:

Quick Answer
The JB Chemicals and Pharmaceuticals share price target for 2026 is Rs 2,221 to Rs 2,490, which is between 8 percent below and 3 percent above the last close of Rs 2,425.10, with bull and bear cases of Rs 2,963 to Rs 3,233 and Rs 1,517 to Rs 1,706. J.B. Chemicals and Pharmaceuticals merged into Torrent Pharmaceuticals effective 8 July 2026 at a ratio of 51 Torrent shares for every 100 JB shares, so JB shares no longer trade and each old share is worth about Rs 2,425 at Torrent's 5 October close of Rs 4,755. The record date was 17 July, Torrent allotted 4.19 crore new shares on 20 July and listed them on 28 July, and the ranges below value one JB share as 0.51 of a Torrent share. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario.
The JB Chemicals and Pharmaceuticals share price target for 2026 is Rs 2,221 to Rs 2,490 in the Univest base case, with the stock at Rs 2,425.10 at the 5 October 2026 close. That is 4.0 percent below its 52-week high of Rs 2,525.50 and 47.5 percent above its 52-week low of Rs 1,644.60, and the stock moved up 44.9 percent over the past year. J.B. Chemicals and Pharmaceuticals was an Indian pharma company that Torrent Pharmaceuticals took control of in January 2026 in a deal valued at Rs 25,689 crore.
Three things changed since the last update: the NCLT order was filed and the merger became effective on 8 July 2026, JB shareholders received Torrent shares on the 17 July record date, and the new Torrent shares began trading on 28 July. This JB Chemicals and Pharmaceuticals stock analysis covers the JB Chemicals and Pharmaceuticals share price today, the JB Chemicals and Pharmaceuticals share price target for 2026, 2027 and 2030, the Torrent Merger numbers, catalysts and risks, key price levels and a JB Chemicals and Pharmaceuticals buy or sell view.
Click Here – Get Free Investment Predictions
What Is the JB Chemicals and Pharmaceuticals Share Price Target for 2026?
The 2026 target for JB Chemicals and Pharmaceuticals shares is Rs 2,221 to Rs 2,490 in the Univest base case, which is -8.4% to +2.7% against the last close. The bull case is Rs 2,963 to Rs 3,233 and the bear case is Rs 1,517 to Rs 1,706. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.
JB Chemicals and Pharmaceuticals Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS per JB Share | Target Multiple | Price Target (Rs) | Move vs Rs 2,425.10 |
|---|---|---|---|---|
| Bull Case | Rs 44.9 | 66x to 72x | 2,963 to 3,233 | +22.2% to +33.3% |
| Base Case | Rs 38.3 | 58x to 65x | 2,221 to 2,490 | -8.4% to +2.7% |
| Bear Case | Rs 31.6 | 48x to 54x | 1,517 to 1,706 | -37.4% to -29.7% |
Because JB shares no longer trade, the ranges value one old JB share as 0.51 of a Torrent share, using Univest assumptions of FY28 Torrent EPS of Rs 75 and a multiple of 58 to 65 times, which gives JB equivalent EPS of Rs 38.30. Trailing Torrent EPS is Rs 56.68 and the stock trades at about 84 times it. The PE multiple and ratios in this section are for Torrent Pharma, which now holds the JB business, and the EPS estimate per JB share is 0.51 of a Univest estimate for Torrent, not company guidance. Those assumptions set the JB Chemicals and Pharmaceuticals share price target range around the current price.
JB Chemicals and Pharmaceuticals Company Overview and Share Price Today as of 5 October 2026
JB Chemicals and Pharmaceuticals share price today is Rs 2,425.10 on the NSE at the 5 October 2026 close, before the market opened on 6 October. The market capitalisation is Rs 1,80,871 crore (Torrent Pharma), and these ratios are for Torrent Pharma, which now holds the JB business. The Univest base case JB Chemicals and Pharmaceuticals share price target of Rs 2,221 to Rs 2,490 is -8.4% to +2.7% from here. The table below sets out the key numbers behind the JB Chemicals and Pharmaceuticals share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | JBCHEPHARM | BSE code 506943 |
| Sector | Pharmaceuticals (merged into Torrent Pharma) | Per Univest sector classification |
| Last Close (NSE) | Rs 2,425.10 | 5 Oct 2026 close |
| 52-Week High | Rs 2,525.50 | CMP is 4.0% below |
| 52-Week Low | Rs 1,644.60 | CMP is 47.5% above |
| 1-Year Return (Swap Value) | About +45% | Weekly close Rs 1673.3 on 10 Oct 2025 to Rs 2425.1 |
| Market Capitalisation | Rs 1,80,871 crore (Torrent Pharma) | Large cap pharma after the merger |
| Trailing P/E | About 83.9x (Torrent) | Industry P/E about 37.53x |
| P/B Ratio | About 21.5x (Torrent) | Book value Rs 221.09 per share |
| EPS (TTM) | Rs 56.68 | Trailing twelve months |
| Return on Equity | About 25.5% (Torrent) | Debt to equity 1.79 |
| Dividend Yield | About 0.71% | Torrent dividend yield |
| 12-Month Target (Base Case) | Rs 2,221 to Rs 2,490 | Univest base case |
| Bull Case | Rs 2,963 to Rs 3,233 | +22.2% to +33.3% |
| Bear Case | Rs 1,517 to Rs 1,706 | -37.4% to -29.7% |
How Did JB Chemicals and Pharmaceuticals Perform in Torrent Merger?
JB Chemicals no longer reports results as a separate listed company, because the merger with Torrent Pharma became effective on 8 July 2026 with 21 January 2026 as the appointed date. Its last traded weekly close was Rs 2,408.90 in the week of 13 July 2026, and the high of that week was Rs 2,525.50. Together these Torrent Merger numbers anchor the JB Chemicals and Pharmaceuticals share price target.
| Metric | Torrent Merger | Context |
|---|---|---|
| Effective Date | 8 July 2026 | After NCLT order of 6 July |
| Appointed Date | 21 January 2026 | Torrent bought 46.39% from Tau (KKR) |
| Exchange Ratio | 51 for 100 | 51 Torrent shares per 100 JB shares |
| Record Date | 17 July 2026 | Allotment on 20 July |
| New Torrent Shares | 4,19,22,416 | Trading from 28 July 2026 |
| Last JB Weekly Close | Rs 2,408.90 | Week of 13 July 2026 |
Aman Mehta, Managing Director of Torrent Pharma, became Managing Director of JB, and the merged company plans to focus on the Indian pharma market. Shareholder approvals came in April 2026 and the final listing approval for the new shares came on 27 July. The FY27 outlook from management is the main input for these estimates. These numbers sit behind every range in the scenario table above, so they anchor the JB Chemicals and Pharmaceuticals share price target.
Why Does JB Chemicals Share Price Now Track Torrent Pharma?
JB Chemicals no longer has its own price because the merger made every old share a claim on 0.51 of a Torrent share. The value of one JB share therefore moves with Torrent's price, which closed at Rs 4,755 on 5 October 2026, an implied Rs 2,425.
Before the merger the stock rose from Rs 1,673 in October 2025 to a high of Rs 2,525.50 in July 2026, a gain of about 44 percent on the swap value of Rs 2,425. The last traded close was Rs 2,408.90 in the week of 13 July. The JB Chemicals and Pharmaceuticals share price target scenarios below account for that move.
Key Catalysts for the JB Chemicals and Pharmaceuticals Share Price Target in 2026
4 catalysts matter most for the JB Chemicals and Pharmaceuticals share price target, and sector tailwinds in Pharmaceuticals (merged into Torrent Pharma) are part of the case. Together they decide whether the base case is reached.
1. Merger Synergies
Torrent bought control for a deal valued at Rs 25,689 crore and merged JB's brands into its Indian portfolio. Shared distribution can lift margin. If it plays out, the JB Chemicals and Pharmaceuticals share price target moves toward the top of the base range.
2. India Pharma Focus
The merged company plans to focus on the Indian pharma market as its main growth engine. A larger domestic franchise supports earnings. Strength here would support the upper end of the JB Chemicals and Pharmaceuticals share price target.
3. Leadership Continuity
Aman Mehta, Managing Director of Torrent, also became Managing Director of JB for three years. Common leadership speeds integration. Delivery on this point keeps the JB Chemicals and Pharmaceuticals share price target on track.
4. Earnings Growth
Trailing Torrent EPS is Rs 56.68 and return on equity is 25.5 percent. Higher earnings after the merger would support the swap value. Better news here would lift the JB Chemicals and Pharmaceuticals share price target toward the bull case.
What Are the Key Risks to the JB Chemicals and Pharmaceuticals Share Price Target?
The main risks are Torrent's high valuation, integration, debt and a fall in Torrent's share price. Each can pull the JB Chemicals and Pharmaceuticals share price target lower.
High Valuation
Torrent trades at 84 times trailing earnings and 21.5 times book value. A fall to 48 times FY28 EPS of Rs 62 would put one JB share near Rs 1,517. If it materialises, the JB Chemicals and Pharmaceuticals share price target would slip toward the bear case.
Integration Risk
Combining two sales forces and brand portfolios can slow growth. Delays would defer the synergies. This is the main downside risk to the JB Chemicals and Pharmaceuticals share price target.
Higher Debt
Torrent's debt to equity is 1.79 after funding the JB deal. Rising interest costs would cut profit. A worsening here would cut the JB Chemicals and Pharmaceuticals share price target toward the low end of the range.
Price Dependence
The swap value moves one for one with Torrent's price. A 10 percent fall in Torrent cuts the JB equivalent by Rs 243. Watch it closely, because it can pull the JB Chemicals and Pharmaceuticals share price target lower quickly.
JB Chemicals and Pharmaceuticals Stock Analysis: Support and Resistance Levels for the Share Price Target
JB Chemicals and Pharmaceuticals stock analysis on weekly charts shows a swap value of about Rs 2,425 per JB share, against a last traded range of Rs 2,236 to Rs 2,525 in July.
The first support level is about Rs 2,380, the low of the last JB weekly candle. Below that, Rs 2,350 is the low of the week of 6 July and Rs 2,236 is the low of the week of 29 June.
The first resistance level is about Rs 2,474, the high of the week of 6 July. Above that, Rs 2,525.50 was the last 52-week high for JB before it stopped trading. These levels come from weekly price action, are not trade recommendations, and frame the near-term JB Chemicals and Pharmaceuticals share price target.
JB Chemicals and Pharmaceuticals Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term JB Chemicals and Pharmaceuticals Share Price Target (3 to 6 Months)
In the near term the swap value is likely to trade between Rs 2,350 and Rs 2,525 per JB share, in line with the last JB trading range, and it will move with Torrent's price. A move in Torrent above Rs 4,950 would lift it past Rs 2,525, while a fall under Rs 4,600 would pull it under Rs 2,350. Torrent's Q2 FY27 results are the main trigger. This range anchors the near-term JB Chemicals and Pharmaceuticals share price target.
12-Month and 2027 JB Chemicals and Pharmaceuticals Share Price Target
The 12-month target price is Rs 2,221 to Rs 2,490, valued on 58 to 65 times FY28 EPS of Rs 38.3. The range across scenarios runs from Rs 1,517 in the bear case to Rs 3,233 in the bull case.
Long-Term JB Chemicals and Pharmaceuticals Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 2,328 to Rs 3,287. This assumes EPS of Rs 48.5 in FY29 and Rs 58.7 in FY30 and a multiple of 48 to 56 times. It needs Torrent Pharma to keep growing earnings after absorbing JB's brands. This is the long-term JB Chemicals and Pharmaceuticals share price target in the Univest scenarios.
Bull Case and Bear Case for JB Chemicals and Pharmaceuticals Share Price Target
Bull Case Rs 2,963 to Rs 3,233
The bull case of Rs 2,963 to Rs 3,233 for the JB Chemicals and Pharmaceuticals share price target needs EPS of Rs 44.9 and the market to pay 66 to 72 times for it. It is +22.2% to +33.3% from the last close.
Bear Case Rs 1,517 to Rs 1,706
The bear case of Rs 1,517 to Rs 1,706 for the JB Chemicals and Pharmaceuticals share price target equals 48 to 54 times FY28 EPS of Rs 31.6 and sits near the Rs 1644.6 low. It is -37.4% to -29.7% from the last close.
Is JB Chemicals and Pharmaceuticals a Good Buy at Rs 2,425? JB Chemicals and Pharmaceuticals Buy or Sell View
Whether JB Chemicals and Pharmaceuticals is a buy at Rs 2,425.10 depends on horizon and risk appetite. The base case sits between 8 percent below and 3 percent above the current price, and the question is Torrent's valuation, not JB's. The JB Chemicals and Pharmaceuticals share price target range is the starting point for that decision.
Former JB holders may focus on Torrent's earnings growth, debt and integration, and treat Rs 2,380 as the level to watch. New buyers can no longer buy JB and would buy Torrent Pharma shares instead. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this JB Chemicals and Pharmaceuticals buy or sell view is educational.
How to Invest in JB Chemicals and Pharmaceuticals Shares
Step 1: Check the live price, valuation and the latest JB Chemicals and Pharmaceuticals share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any JB Chemicals and Pharmaceuticals share price target.
Step 3: Search for Torrent Pharmaceuticals (TORNTPHARM on the NSE, 500420 on the BSE) in your trading app, because JB shares no longer trade.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 1,517 is bearable.
Step 5: Track Torrent's share price, integration and Q2 FY27 results and set price alerts on the Univest App to follow any change in the JB Chemicals and Pharmaceuticals share price target.
Conclusion
JB Chemicals and Pharmaceuticals closed at Rs 2,425.10 against a Univest base case share price target of Rs 2,221 to Rs 2,490, a bull case of Rs 2,963 to Rs 3,233 and a bear case of Rs 1,517 to Rs 1,706. The merger became effective on 8 July 2026 at 51 Torrent shares for every 100 JB shares, so one old JB share is worth about Rs 2,425. The main risks are Torrent's valuation, integration and debt.
The stock is 4.0 percent below its 52-week high, so the base case sits between 8 percent below and 3 percent above the current price. The triggers to watch are Torrent's share price, integration and Q2 FY27 results and the Rs 2,380 and Rs 2,474 levels. Re-check the JB Chemicals and Pharmaceuticals share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track JB Chemicals and Pharmaceuticals live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on JB Chemicals and Pharmaceuticals Share Price Target 2026
What is the JB Chemicals and Pharmaceuticals share price target for 2026?
Ans. The JB Chemicals and Pharmaceuticals share price target for 2026 is Rs 2,221 to Rs 2,490 in the Univest base case, with a bull case of Rs 2,963 to Rs 3,233 and a bear case of Rs 1,517 to Rs 1,706. No brokerage target was available on the sources we track as of 5 October 2026, so these are Univest research scenarios. These are estimates and can change after the Q2 FY27 results.
What is the JB Chemicals and Pharmaceuticals share price target for 2027?
Ans. The JB Chemicals and Pharmaceuticals share price target for 2027 is Rs 2,221 to Rs 2,490 in the base case, valued on 58 to 65 times FY28 EPS of Rs 38.3. The scenario range runs from Rs 1,517 to Rs 3,233.
Is JB Chemicals and Pharmaceuticals a good buy at Rs 2,425.10?
Ans. Whether JB Chemicals and Pharmaceuticals is a good buy at Rs 2,425.10 depends on your horizon, risk appetite and how you read the JB Chemicals and Pharmaceuticals share price target. JB shares can no longer be bought, so the question is whether to hold the Torrent shares received, and that stock trades at about 84 times earnings. Consult a SEBI-registered advisor before investing.
What are the key risks to the JB Chemicals and Pharmaceuticals share price target?
Ans. The key risks to the JB Chemicals and Pharmaceuticals share price target are high valuation, integration risk, higher debt and price dependence. Torrent trades at 84 times trailing earnings and 21.5 times book value. A fall to 48 times FY28 EPS of Rs 62 would put one JB share near Rs 1,517.
What are the key catalysts for the JB Chemicals and Pharmaceuticals share price target?
Ans. The key catalysts for the JB Chemicals and Pharmaceuticals share price target are merger synergies, india pharma focus, leadership continuity and earnings growth. Torrent bought control for a deal valued at Rs 25,689 crore and merged JB's brands into its Indian portfolio. Shared distribution can lift margin.
Where can I track JB Chemicals and Pharmaceuticals share price today and JB Chemicals and Pharmaceuticals share price target updates?
Ans. You can track the live JB Chemicals and Pharmaceuticals share price, results and any change to the JB Chemicals and Pharmaceuticals share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are JB Chemicals and Pharmaceuticals's 52-week high and low?
Ans. JB Chemicals and Pharmaceuticals's 52-week high is Rs 2,525.50 and its 52-week low is Rs 1,644.60, based on weekly NSE data. At Rs 2,425.10 the stock is 4.0 percent below the high and 47.5 percent above the low. Both levels frame the JB Chemicals and Pharmaceuticals share price target.
How to buy JB Chemicals and Pharmaceuticals shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for JBCHEPHARM on the NSE or 506943 on the BSE, and place a limit order near your entry price, using the JB Chemicals and Pharmaceuticals share price target range as a guide. Size the position so a fall to Rs 1,517 is bearable, and check the live price on the Univest Screener first.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





